Peter Wark
Overview
Explore the profile of Peter Wark including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
713
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lew C, Lin C, Lukies M, Wark P, Birks S, Vanguardia M, et al.
ANZ J Surg
. 2025 Mar;
PMID: 40033632
Background: Distal intestinal obstruction syndrome (DIOS) presents significant management challenges for people with cystic fibrosis (pwC). We evaluated the treatment outcomes and identified risk factors associated with the need for...
2.
Sullivan S, Khvorov A, Carolan L, Dowson L, Hadiprodjo J, Sanchez-Ovando S, et al.
Res Sq
. 2024 Oct;
PMID: 39372918
Influenza vaccine effectiveness and immunogenicity can be compromised with repeated vaccination. We assessed immunological markers in a cohort of healthcare workers (HCW) from six public hospitals around Australia during 2020-2021....
3.
Brusselle G, Blasi F, Gessner C, Kuna P, Wark P, Cappellini G, et al.
ERJ Open Res
. 2024 Oct;
10(5).
PMID: 39351383
Introduction: Inhaled corticosteroid/formoterol fumarate (ICS/FF) as needed is recommended by the Global Initiative for Asthma (GINA) as sole therapy in adults with mild asthma, with low-dose maintenance ICS plus short-acting...
4.
Lord L, Wark P, Hew M, Blakeley B, Steeper M, Kirsa S, et al.
J Psychosom Res
. 2024 Aug;
186:111877.
PMID: 39178579
Objective: People living with cystic fibrosis (PwCF) are at increased risk of mental health conditions. There is little evidence addressing psychotropic medication use in PwCF. This study aimed to estimate...
5.
Denton E, Wark P, Hew M
Respirology
. 2024 Jun;
29(8):656-658.
PMID: 38887939
No abstract available.
6.
Shahaj O, Meiwald A, Puri Sudhir K, Gara-Adams R, Wark P, Cazaux A, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Jun;
19:1207-1223.
PMID: 38831892
Purpose: Chronic obstructive pulmonary disease (COPD) poses a significant global health burden despite being largely preventable and treatable. Despite the availability of guidelines, COPD care remains suboptimal in many settings,...
7.
Chandrasekara S, Wark P
Aust Prescr
. 2024 May;
47(2):36-42.
PMID: 38737370
Asthma is a chronic inflammatory airways disease with reversible airflow obstruction, characterised in the majority by type 2 airway inflammation. Type 2 inflammation results in secretion of interleukin-4, -5 and...
8.
Marchant J, Chang A, Kennedy E, King D, Perret J, Schultz A, et al.
Med J Aust
. 2023 Nov;
220(1):35-45.
PMID: 37982357
Introduction: Cough is the most common symptom leading to medical consultation. Chronic cough results in significant health care costs, impairs quality of life, and may indicate the presence of a...
9.
Wang H, Yip K, Keam S, Vlahos R, Nichol K, Wark P, et al.
J Allergy Clin Immunol
. 2023 Nov;
153(3):672-683.e6.
PMID: 37931708
Background: Patients with severe asthma can present with eosinophilic type 2 (T2), neutrophilic, or mixed inflammation that drives airway remodeling and exacerbations and represents a major treatment challenge. The common...
10.
Liu Y, Sanchez-Ovando S, Carolan L, Dowson L, Khvorov A, Hadiprodjo A, et al.
Vaccine
. 2023 Oct;
41(48):7192-7200.
PMID: 37903679
Both vector and mRNA vaccines were an important part of the response to the COVID-19 pandemic and may be required in future outbreaks and pandemics. The aim of this study...